FIELD: medicine.
SUBSTANCE: invention concerns medicine and biotechnology. There is disclosed application of coding DNA for making virus-like particles of hepatitis C virus, as well as the method for making the specified particles and a pharmaceutical composition using the same. The virus-like particles cause induction of interferon system in vivo.
EFFECT: invention can be used for making a preparation for prevention and treatment of the HCV-related conditions, as well as diagnostics thereof.
5 cl, 4 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT VECTORS BASED ON 'LIVE' VIRUS OF FOWL POX AND THEIR APPLICATION IN PHARMACEUTICAL COMPOSITIONS AGAINST VIRUS OF HEPATITIS C | 2005 |
|
RU2353651C2 |
| PRODUCTION OF VIRUS-LIKE PARTICLES IN PLANTS | 2011 |
|
RU2655431C2 |
| VACCINAL COMPOSITION AGAINST HEPATITIS C VIRUS | 2005 |
|
RU2351363C2 |
| RESISTANT MUTANTS OF PROTEASE NS3-NS4A HCV | 2004 |
|
RU2365624C2 |
| OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS | 1999 |
|
RU2247729C2 |
| VIRIONS AND VIRUS-LIKE PARTICLES OF ALTERNANTHERA MOSAIC VIRUS AS AMPLIFIERS OF IMMUNE RESPONSE | 2015 |
|
RU2639491C2 |
| USING TYPE III PEGYLATED INTERFERONS FOR TREATING HEPATITIS C | 2009 |
|
RU2496514C2 |
| CONJUGATES OF PEPTIDE Melan-A, VIRUS-LIKE PARTICLE ANALOGUE | 2004 |
|
RU2351362C2 |
| THERAPEUTIC AGENT FOR TREATING VIRAL HEPATITIS C | 2014 |
|
RU2568872C1 |
| VACCINE OF VIRUS-LIKE PARTICLES CONTAINING ALL HEPATITIS C VIRUS STRUCTURAL ANTIGENS, AND METHOD FOR PREPARING IT IN Hansenula polymorpha YEAST | 2012 |
|
RU2510998C2 |
